SecBot SecBot
PRESS-RELEASE ·Filed Sep 16, 2026

MYGN

Myriad Genetics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago WireGlobeNewswire
Press release · Leadership
Actionable Insight • Neutral

Leadership change is routine and unlikely to move the stock. Monitor next quarterly earnings for any commercial execution impact under new leadership.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$3.86
T+0 close · Sep 16, 2026 · via day close
Latest settled
+5.70%
T+20 · $4.08 · next T+60 in 23d
Vs SPY
+2.52%
α at T+20
Latest observation
+81.02%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $3.86entry
  2. T+1 · 2mo ago +7.25%α +6.12% · $4.14
  3. T+5 · 8w ago +3.89%α +1.32% · $4.01
  4. T+20 · 5w ago +5.70%α +2.52% · $4.08
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Myriad Genetics announced the promotion of Vishal Sikri to EVP-Commercial, replacing departing CCO Brian Donnelly. The company reaffirmed its full-year 2026 financial guidance. This is a routine leadership change with no material financial impact.

Key Facts

  • Vishal Sikri promoted to EVP-Commercial, effective September 16, 2026.
  • Brian Donnelly, Chief Commercial Officer since May 2025, departing September 21, 2026.
  • Full-year 2026 financial guidance reaffirmed.

Financial Impact

No financial figures provided; guidance reaffirmed.

Risk Factors

  • Departure of CCO Brian Donnelly after ~16 months could signal commercial challenges.
  • No new financial targets or updates provided.

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
13% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3363090

Track record

16 reports on MYGN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry price pending
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  4. Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  5. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
  7. Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
  8. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
  9. Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
  10. Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (10h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026